Free shipping over €250 · Tracked, discreet delivery in Europe

Long-acting growth hormone

Somapacitan

Sogroya

Approved medicineNot yet reviewedProtein

In short: A weekly growth hormone analogue approved for growth hormone deficiency.

Regulatory status

  1. Cosmetic ingredient
  2. Research compound
  3. In clinical trials
  4. Approved medicine

Approved as a medicine by the FDA or the EMA for at least one indication. Approval covers the named indication and formulation only.

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Common questions

Is Somapacitan an approved medicine?

Approved medicine. Approved as a medicine by the FDA or the EMA for at least one indication. Approval covers the named indication and formulation only.

How much human research is there on Somapacitan?

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Does UU supply Somapacitan?

No. It appears in the library for reference only, so the field can be read in one place.

More in Hormones & growth

Back to the library

The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.